Inc., a nanotechnology-based filtration development company, today announced
that it has committed to fully assist its future merger partner Emergency Filtration
Products, Inc. (EFP), the developer of the NanoMask™, in the response
to comments issued by the U.S. Food and Drug Administration (FDA) in relation
to the 510(k) pre-market notification filed by EFP in connection with the NanoMask.
"We have been working diligently to help EFP prepare the response to FDA
comments regarding the NanoMask pre-market notification, especially as it relates
to the antimicrobial silver nanoparticle formulation which powers the NanoMask,"
said Thomas K. Allen, President and CEO, ANI. "Applied Nanoscience's management
and scientific team plan to rapidly provide EFP with the necessary data to satisfy
the FDA comments."